Page 51 - Read Online
P. 51

Table 1: Case reports of combined sarcomatoid hepatocellular carcinoma and cholangiocarcinoma
          Study        Age, gender  Symptoms              Hepatitis serology Treatment  Follow-up and prognosis
          Nakajima et al. [4]  74 years, male  Right upper quadrant pain  HBsAb  TACE  Lung metastasis; death at 17 months;
                                                                                      diagnosis at autopsy
          Papotti et al. [5]  59 years, male  Lumbar pain  Negative     Hepatectomy   Biliary fi stula; death at 4 months
          Jeong et al. [6]  60 years, female Right upper quadrant pain/mass NA  Hepatectomy  Tumor recurrence; death at 12 months
          Kim et al. [7]  67 years, male  Synchronous colon tumor  NA   NA            NA
          Boonsakan et al. [8]  28 years, male  Fever     HBsAg         Palliative resection Lost to follow-up
          Pua et al. [9]  71 years, male  Fever, weight loss, anorexia  Negative  Hepatectomy  Lung and pleural metastasis; death
                                                                                      at 6 weeks
          NA: not available; HBsAb: hepatitis B surface antibody; HBsAg: hepatitis B surface antigen; TACE: trans-arterial chemoembolization

          ordinary HCC with positive hepatitis serology, cirrhosis and   were divided according to the percentage of CC. Sarcomatous
          raised AFP levels. Liver function parameters may or may not   patients were found to have significantly higher chance of
          be unstable depending on the size of the tumor and degree of   vascular invasion, lymph node metastasis as well as high
          underlying cirrhosis. The liver was grossly cirrhotic [Figure 4]   CC percentage group, and were associated with a much
          in our patient; however, his child’s score was only Class A. This   shorter survival compared to those without a sarcomatous
          might be attributed to his relatively large liver volume reserve   and lower CC component (P < 0.0048). Such aggressive
          compensating for cirrhosis. Some authors have reported   lesions make the diagnosis and treatment difficult. Patients
          high fever and abdominal pain as frequent symptoms of   are either diagnosed only at post-mortem or at an advanced
          sarcomatoid HCC. [13,16]  Although these were not present in   unresectable stage. There is currently no recommended
          this patient, the suspicion of liver abscess based on these   treatment strategy for sarcomatoid carcinomas, and surgical
          symptoms may delay and make the diagnosis more difficult.   resection appears to be the only curative option, albeit only
          In a patient described by Inoue et al.,  abscess drainage   at the early stage of tumor formation. There is yet no report
                                          [13]
          followed by biopsy were performed before the diagnosis was   of successful adjuvant treatment with chemotherapy or
          made. At 3 weeks after admission, there was already pleural   radiotherapy described in the literature to prolong survival
          metastasis. Despite a trial of chemotherapy, the patient died   in patients with this aggressive tumor.
          of multiorgan failure on day 27. Radiologically, our patient’s
          tumor was also suggestive of HCC with arterial enhancement   In conclusion, a case of hepatic combined sarcomatoid HCC
          and portovenous contrast washout. Honda et al.  described   and CC is reported here. This is an extremely rare tumor with
                                                 [17]
          delayed or prolonged contrast enhancement as a feature   an aggressive behavior. The prognosis is extremely poor, and
          of sarcomatoid HCC. This finding may be attributed to the   survival has been limited to within a few months in most
          presence of active cancerous tissue with fibrous stroma.   cases. Pre-operative diagnosis and distinction from ordinary
          The aggressiveness of this type of tumor is highlighted by   HCC is difficult. Reports in the literature suggest surgery as
          the high incidence of local invasion and metastatic spread   the treatment of choice at present. Due to the rarity of the
          either at the time of surgery or early recurrence. Indeed,   disease, adjuvant chemotherapy or radiotherapy has not
          there was invasion into the right hemidiaphragm of > 50%   shown any promise. Early diagnosis with a high index of
          in our patient. Both intra and extrahepatic metastasis as well   suspicion appears to give the best chance of cure.
          as lymphadenopathy is common.  Metastasis to multiple
                                      [16]
          organs including the lungs, hepatic hilar lymph nodes, greater
          omentum, stomach and diaphragm as seen in our patient     REFERENCES
          have been reported. [4]
                                                              1.   Koo HR, Park MS, Kim MJ, Lim JS, Yu JS, Jin H, Kim KW. Radiological
                                                                  and clinical features of sarcomatoid hepatocellular carcinoma in
          Prognosis is inevitably poor with such aggressive behavior   11 cases. J Comput Assist Tomogr 2008;32:745-9.
          of these tumors with high risk of metastasis. In the cases   2.   Lao XM, Chen DY, Zhang YQ, Xiang J, Guo RP, Lin XJ, Li JQ. Primary
          reported in the literature, most patients have developed   carcinosarcoma of the liver: clinicopathologic features of 5 cases and a
          metastatic lesions within 3-6 months of diagnosis and   3.   review of the literature. Am J Surg Pathol 2007;31:817-26.
                                                                  Maeda  T, Adachi E, Kajiyama K,  Takenaka K, Sugimachi K,
          survival rarely exceeded 12 months. This is exemplified   Tsuneyoshi M. Spindle cell hepatocellular carcinoma. A clinicopathologic
          in the present patient, where metastatic lymph nodes    and immunohistochemical analysis of 15 cases. Cancer 1996;77:51-7.
          and peritoneal nodules were already identified 1-month   4.   Nakajima T, Kubosawa H, Kondo Y, Konno A, Iwama S. Combined
          post-surgical resection. In a study reported by Aishima   hepatocellular-cholangiocarcinoma with variable sarcomatous
                                                                  transformation. Am J Clin Pathol 1988;90:309-12.
          et al.,  7 (17.5%) out of 40 patients had a sarcomatous   5.   Papotti M, Sambataro D, Marchesa P, Negro F. A combined
               [18]
          component in combined HCC and CC. The rest of the patients   hepatocellular/cholangiocellular carcinoma with sarcomatoid features.

          44                                                          Hepatoma Research | Volume 1 | Issue 1 | April 15, 2015
   46   47   48   49   50   51   52   53   54   55   56